Global Implantable Remote Patient Monitoring Devices Market
Description
Report Scope
The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Includes
32 data tables and 47 additional tables
An overview of the global market for implantable remote patient monitoring (IRPM) devices
Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
A discussion of the industry’s ESG challenges and practices
Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
Identification of the major stakeholders and analysis of recent developments and segmental revenues
Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik
Companies Mentioned
ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT
The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Includes
32 data tables and 47 additional tables
An overview of the global market for implantable remote patient monitoring (IRPM) devices
Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
A discussion of the industry’s ESG challenges and practices
Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
Identification of the major stakeholders and analysis of recent developments and segmental revenues
Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik
Companies Mentioned
ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT
Table of Contents
140 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope Of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Pestel Analysis
- Political
- Economic
- Social
- Technological
- Environmental
- Legal
- Porter's Five Forces Analysis
- Bargaining Power Of Buyers
- Bargaining Power Of Suppliers
- Potential For New Entrants
- Threat Of Substitutes
- Competition In The Industry
- Supply Chain Analysis
- R&D, Product Design And Early Prototyping
- Regulatory Submissions And Approvals
- Raw Material Procurement
- Manufacturing Irpm Devices
- Distribution And Sales
- Post-sales Services
- Chapter 3 Market Dynamics
- Market Dynamics Overview
- Market Drivers
- Increasing Prevalence Of Chronic Diseases And An Aging Population
- Growing Demand For Mhealth Applications
- Improved Wireless Communication Technologies
- Market Restraints
- Data Privacy Concerns
- Stringent Government Regulations
- Market Opportunities
- Emerging Markets
- Market Challenges
- Integration With Healthcare Systems
- Chapter 4 Regulatory Landscape
- Regulatory Framework
- United States
- European Union
- Japan
- Chapter 5 Emerging Technologies And Developments
- Emerging Technologies In The Irpm Devices Market
- Artificial Intelligence And Machine Learning
- Nanotechnology-based Devices
- Biocompatible Materials
- Patent Analysis
- Patents By Year
- Patents By Top Applicant
- Patents By Top Owner
- Patents By Top Inventor
- Patents By Jurisdiction
- Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Irpm Devices: Global Markets
- Market Analysis By Product
- Implantable Cardiovascular Monitoring Devices
- Implantable Brain Monitoring Devices
- Gastrointestinal Monitoring (Smart Pills)
- Implantable Hematological Monitoring Devices
- Implantable Respiratory Monitoring Devices
- Implantable Musculoskeletal Monitoring Devices
- Others
- Market Analysis By Indication
- Cardiovascular Diseases
- Brain Disorders
- Gastrointestinal Diseases
- Diabetes
- Chronic Respiratory Diseases
- Musculoskeletal Diseases
- Others
- Market Analysis By End User
- Hospital And Clinics
- Home Healthcare Settings
- Other End-users
- Geographic Breakdown
- Market Analysis By Region
- North America
- Europe
- Asia-pacific
- Rest Of The World
- Chapter 7 Sustainability: An Esg Perspective In Irpm Devices
- Sustainability In The Irpm Devices Industry
- Understanding The Esg Data
- Concluding Remarks From Bcc
- Chapter 8 Competitive Intelligence
- Overview
- Key Strategies For Irpm Devices Manufacturers
- Distribution Networks
- Product Mapping
- Chapter 9 Appendix
- Methodology
- Abbreviations
- Sources
- Company Profiles
- Abbott
- Avertix Medical Inc.
- Biotronik
- Boston Scientific Corp.
- Cardiac Rms
- Dexcom Inc.
- Ebr Systems Inc.
- Endotronix Inc.
- Injectsense Inc.
- Impulse Dynamics
- Medico S.R.L.
- Medtronic
- Profusa Inc.
- Qura Llc.
- Vitalconnect
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
